SCTBIO
Live / Registered — Registered (as of 09 Jul 2024)
What this means for you
Registered since 09 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79337464
- Registration number
- 7435168
- Mark type
- Stylized text
- Filed
- 09 Feb 2022
- Published for opposition
- 23 Apr 2024
- Registered
- 09 Jul 2024
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 039 — Transportation and storage services: Labeling, relabeling, storage and distribution of cell therapy materials
- Class 040 — Treatment of materials: Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others
- Class 042 — Scientific and technological services: Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies
Owner
- SCT CELL MANUFACTURING S.R.O., CZ-170 00 PRAGUE 7, CZ
- SCT CELL MANUFACTURING S.R.O., CZ-170 00 PRAGUE 7, CZ
- SCT CELL MANUFACTURING S.R.O., CZ-170 00 PRAGUE 7, CZ
- SCTbio a.s., XP
Prosecution history
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jan 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Dec 2024 — FINAL DISPOSITION PROCESSED
- 09 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION
- 22 Apr 2024 — NOTIFICATION PROCESSED BY IB
- 03 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB